{"id":21027,"date":"2026-07-31T10:33:40","date_gmt":"2026-07-31T10:33:40","guid":{"rendered":"https:\/\/woncaeurope2026.org\/sessions\/expanding-anp-roles-leading-benzodiazepine-deprescribing-in-primary-care\/"},"modified":"2026-07-31T10:33:40","modified_gmt":"2026-07-31T10:33:40","slug":"expanding-anp-roles-leading-benzodiazepine-deprescribing-in-primary-care","status":"publish","type":"wsa_session","link":"https:\/\/woncaeurope2026.org\/fr\/sessions\/expanding-anp-roles-leading-benzodiazepine-deprescribing-in-primary-care\/","title":{"rendered":"Expanding ANP Roles: Leading Benzodiazepine Deprescribing in Primary Care"},"content":{"rendered":"<p>Benzodiazepines are primarily used for short periods to manage acute anxiety, addiction, agitation and neurological disorders (The Medical Council 2025). Long term use poses risks to patient safety (HSE 2021). A candidate advanced nurse practitioner (cANP) led initiative was formulated in our practice, aiming to reduce repeat prescribing of benzodiazepines in general practice, in an area of social deprivation.<\/p>\n","protected":false},"template":"","class_list":["post-21027","wsa_session","type-wsa_session","status-publish","hentry","description-off"],"_links":{"self":[{"href":"https:\/\/woncaeurope2026.org\/fr\/wp-json\/wp\/v2\/wsa_session\/21027","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/woncaeurope2026.org\/fr\/wp-json\/wp\/v2\/wsa_session"}],"about":[{"href":"https:\/\/woncaeurope2026.org\/fr\/wp-json\/wp\/v2\/types\/wsa_session"}],"wp:attachment":[{"href":"https:\/\/woncaeurope2026.org\/fr\/wp-json\/wp\/v2\/media?parent=21027"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}